0
0
1/6/23 at 12:00pm
Organization
Barron's
Author
Josh Nathan-Kazis
40 words
0
Comments
As part of the shift, the company may sell assets like its gene therapy facility in Durham and a cancer-focused R&D group in Denver.
You are the first to view
https://www.barrons.com/articles/pfizer-rare-disease-gene-therapy-51672870246
Create an account
or login to join the discussion